About the Authors

Robert J. Wong

Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Writing – original draft, Writing – review & editing

Rowong@alamedahealthsystem.org

Affiliation Division of Gastroenterology and Hepatology, Alameda Health System–Highland Hospital, Oakland, CA, United States of America

Tram Tran

Roles Conceptualization, Formal analysis, Investigation, Writing – review & editing

Affiliation Gilead Sciences, Foster City, CA, United States of America

Harvey Kaufman

Roles Conceptualization, Data curation, Formal analysis, Writing – review & editing

Affiliation Quest Diagnostics, Secaucus, NJ, United States of America

Justin Niles

Roles Data curation, Formal analysis, Methodology, Writing – review & editing

Affiliation Quest Diagnostics, Secaucus, NJ, United States of America

Robert Gish

Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Supervision, Writing – review & editing

Affiliation Division of Gastroenterology and Hepatology, Stanford Health Care, Palo Alto, CA, United States of America

Competing Interests

I have read the journal's policy and the authors of this manuscript have the following competing interests: Robert Wong: research grants, consulting, advisory board, speaker’s bureau – Gilead Sciences; research grants – Abbvie; speaker’s bureau – Salix, Bayer; research grant – AASLD Foundation; Tram Tran: employee and stocks – Gilead Sciences; Harvey Kaufman: None; Justin Niles: None; Robert Gish: consulting, advisor - Abbot, AbbVie, Alexion, Arrowhead, Bayer AG, Biocollections, Bristol-Myers Squibb Company, Contravir, Eiger, Enyo, eStudySite, Genentech, Gilead Sciences, HepaTX, HepQuant, Hoffmann-LaRoche Ltd., Intellia, Intercept, Ionis Pharmaceuticals, Janssen, MedImmune, Merck, Prometheus, Quest, Shionogi, Transgene, Trimaran; Scientific/clinical Advisory Boards -AbbVie, Merck, Arrowhead, Bayer, Contravir, Dova Pharmaceuticals, Eiger, Enyo, Janssen, Medimmune, Janssen/J&J, Intercept, Shionogi, Spring Bank; Clinical trials – eStudySite. Chair Clinical Advisory Board – Arrowhead; Data Safety Monitoring Board – Ionis; Speaker’s bureau – AbbVie, Alexion, Bayer, BMS, Gilead Sciences Inc., Merck; Minor stock shareholder - Athenex, Triact, Synageva, RiboSciences, CoCrystal; Stock options – Arrowhead, Eiger. The above competing interests statement and funding do not alter our adherence to all PLOS ONE policies on sharing data and materials.